World's Best Scientists 2026 revealed!
Shinji Shimoda

Shinji Shimoda

D-Index & Metrics

Immunology

D-Index
59
Citations
9976
World Ranking
3453
National Ranking
139

Shinji Shimoda publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Shinji Shimoda sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 239 publications — 48th percentile

48% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Shinji Shimoda D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Shinji Shimoda sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 59 D-Index — 32nd percentile

32% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Shinji Shimoda is affiliated with Kyushu University in Japan and has a research focus primarily within the field of Medicine. Their work spans several subfields including Hepatology, Epidemiology, Oncology, Surgery, and Orthodontics.

The scientist's research covers a range of topics, notably:

  • Liver Disease Diagnosis and Treatment
  • Hepatitis C virus research
  • Liver Diseases and Immunity
  • Hepatitis B Virus Studies
  • Pediatric Hepatobiliary Diseases and Treatments
  • Dental Erosion and Treatment
  • Dental materials and restorations

Recent significant publications by Shinji Shimoda include:

  • "Tenofovir alafenamide after switching from entecavir or nucleos(t)ide combination therapy for patients with chronic hepatitis B" (2020) published in Liver International
  • "Switching to tenofovir alafenamide for nucleos(t)ide analogue-experienced patients with chronic hepatitis B: week 144 results from a real-world, multi-centre cohort study" (2022) published in Alimentary Pharmacology & Therapeutics
  • "Safety, tolerability, and anti-fibrotic efficacy of the CBP/β-catenin inhibitor PRI-724 in patients with hepatitis C and B virus-induced liver cirrhosis: An investigator-initiated, open-label, non-randomised, multicentre, phase 1/2a study" (2022) published in EBioMedicine
  • "Integrated GWAS and mRNA Microarray Analysis Identified IFNG and CD40L as the Central Upstream Regulators in Primary Biliary Cholangitis" (2020) published in Hepatology Communications
  • "Ursodeoxycholic acid impairs liver-infiltrating T-cell chemotaxis through IFN-γ and CX3CL1 production in primary biliary cholangitis" (2021) published in European Journal of Immunology

The scientist has frequently published in journals such as:

  • Journal of Hepatology
  • Kanzo
  • Influenza and Other Respiratory Viruses
  • Journal of Gastroenterology and Hepatology
  • Journal of Hard Tissue Biology

Frequent collaborators in their research include:

  • Kazufumi Dohmen
  • Eiichi Ogawa
  • Makoto Nakamuta
  • Norihiro Furusyo
  • Toshimasa Koyanagi

Best Publications

  • HLA DRB4 0101-restricted immunodominant T cell autoepitope of pyruvate dehydrogenase complex in primary biliary cirrhosis: evidence of molecular mimicry in human autoimmune diseases.

    Shinji Shimoda;Minoru Nakamura;Hiromi Ishibashi;Kazuhiro Hayashida

  • Graft-versus-host disease disrupts intestinal microbial ecology by inhibiting Paneth cell production of α-defensins.

    Yoshihiro Eriguchi;Shuichiro Takashima;Hideyo Oka;Sonoko Shimoji

  • Liver‐targeted and peripheral blood alterations of regulatory T cells in primary biliary cirrhosis

    Ruth Y. Lan;Chunmei Cheng;Zhe Xiong Lian;Koichi Tsuneyama

  • Genome-wide association study identifies TNFSF15 and POU2AF1 as susceptibility loci for primary biliary cirrhosis in the Japanese population.

    Minoru Nakamura;Nao Nishida;Minae Kawashima;Yoshihiro Aiba

  • Identification and precursor frequency analysis of a common T cell epitope motif in mitochondrial autoantigens in primary biliary cirrhosis.

    Shinji Shimoda;Shinji Shimoda;Judith A Van de Water;Aftab Ansari;Minoru Nakamura

  • Periductal interleukin‐17 production in association with biliary innate immunity contributes to the pathogenesis of cholangiopathy in primary biliary cirrhosis

    K. Harada;Shinji Shimoda;Y. Sato;K. Isse

  • Liver architecture, cell function, and disease.

    Hiromi Ishibashi;Minoru Nakamura;Atsumasa Komori;Kiyoshi Migita

  • Altered monocyte responses to defined TLR ligands in patients with primary biliary cirrhosis

    Tin K Mao;Zhe-Xiong Lian;Carlo Selmi;Carlo Selmi;Yasunori Ichiki

  • Fractalkine and CX3CR1 are involved in the recruitment of intraepithelial lymphocytes of intrahepatic bile ducts

    Kumiko Isse;Kenichi Harada;Yoh Zen;Takashi Kamihira

  • Human intrahepatic biliary epithelial cells function in innate immunity by producing IL-6 and IL-8 via the TLR4-NF-kappaB and -MAPK signaling pathways.

    Terufumi Yokoyama;Atsumasa Komori;Minoru Nakamura;Yasushi Takii

  • Efficacy of pegylated interferon alpha-2b and ribavirin treatment on the risk of hepatocellular carcinoma in patients with chronic hepatitis C: A prospective, multicenter study

    Eiichi Ogawa;Norihiro Furusyo;Eiji Kajiwara;Kazuhiro Takahashi

  • Lymphocyte recruitment and homing to the liver in primary biliary cirrhosis and primary sclerosing cholangitis

    Andrea T. Borchers;Shinji Shimoda;Christopher Bowlus;Carl L. Keen

  • Interaction between Toll-like receptors and natural killer cells in the destruction of bile ducts in primary biliary cirrhosis

    Shinji Shimoda;Kenichi Harada;Hiroaki Niiro;Ken Shirabe

  • Antibody titer to gp210-C terminal peptide as a clinical parameter for monitoring primary biliary cirrhosis

    Minoru Nakamura;Yuki Shimizu-Yoshida;Yasushi Takii;Atsumasa Komori

  • Mimicry peptides of human PDC-E2 163-176 peptide, the immunodominant T-cell epitope of primary biliary cirrhosis

    Shinji Shimoda;Minoru Nakamura;Hirohisa Shigematsu;Hironori Tanimoto

  • Molecular mimicry of mitochondrial and nuclear autoantigens in primary biliary cirrhosis.

    Shinji Shimoda;Minoru Nakamura;Hiromi Ishibashi;Akira Kawano

  • CX3CL1 (fractalkine): A signpost for biliary inflammation in primary biliary cirrhosis

    Shinji Shimoda;Kenichi Harada;Hiroaki Niiro;Akinobu Taketomi

  • Short-term risk of hepatocellular carcinoma after hepatitis C virus eradication following direct-acting anti-viral treatment.

    E. Ogawa;N. Furusyo;H. Nomura;K. Dohmen

  • T cell immunity in autoimmune hepatitis.

    Yasunori Ichiki;Christopher A. Aoki;Christopher L. Bowlus;Shinji Shimoda

  • Safety, Tolerability, and Preliminary Efficacy of the Anti-Fibrotic Small Molecule PRI-724, a CBP/β-Catenin Inhibitor, in Patients with Hepatitis C Virus-related Cirrhosis: A Single-Center, Open-Label, Dose Escalation Phase 1 Trial

    Kiminori Kimura;Akemi Ikoma;Maki Shibakawa;Shinji Shimoda

  • Biliary epithelial cells and primary biliary cirrhosis: the role of liver-infiltrating mononuclear cells.

    Shinji Shimoda;Kenichi Harada;Hiroaki Niiro;Tomoharu Yoshizumi

Frequent Co-Authors

Hiromi Ishibashi
Hiromi Ishibashi Nagasaki University
Jun Hayashi
Jun Hayashi Haradoi Hospital
Minoru Nakamura
Minoru Nakamura Nagasaki University
Kazuhiro Takahashi
Kazuhiro Takahashi Tohoku University
M. Eric Gershwin
M. Eric Gershwin University of California, Davis
Koichi Akashi
Koichi Akashi Kyushu University
Yoshihiko Maehara
Yoshihiko Maehara Kyushu University
Yasuni Nakanuma
Yasuni Nakanuma Kanazawa University
Kiyoshi Migita
Kiyoshi Migita Fukushima Medical University
Mine Harada
Mine Harada Kyushu University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology in the USA opens doors to various healthcare and research careers. Many students interested in healthcare often consider complementary online programs to boost their qualifications. For those starting without a nursing background, online adn programs for non nurses offer a practical pathway to enter the nursing field quickly while building foundational skills.

Career advancement is another important factor. Accelerated programs such as the 12-month accelerated nursing programs provide an efficient option for those who want to fast-track their education and transition into specialized roles in healthcare or research.

For entry-level positions within patient care, exploring the fastest and easiest lpn programs can be beneficial. These programs prepare students to become Licensed Practical Nurses, opening up early career opportunities while offering flexibility.

Finally, for nurses aiming to expand their responsibilities and expertise, the question “what is the easiest np program” is common. Choosing an accessible Nurse Practitioner program can lead to advanced clinical roles closely tied to immunology research and treatment.

Best Scientists Citing Shinji Shimoda

Trending Scientists

Recently Published Articles